Changbai Mountain Ginseng (Panax ginseng)
Changbai Mountain Ginseng (Panax ginseng) is a regional variety harvested from northeastern China's Changbai Mountain range, valued for its high concentration of ginsenosides — particularly Rg1, Rb1, and Re — which modulate adaptogenic and ergogenic responses. These triterpenoid saponins primarily act on glucocorticoid receptors, HPA axis signaling, and mitochondrial energy metabolism to reduce fatigue and support physical endurance.

Origin & History
Changbai Mountain Ginseng (CMG) is a premium cultivar variant of Panax ginseng C.A. Mey originating from the Changbai Mountain Range in Jilin Province, Northeast China, at altitudes of 1000-2000 meters. The plant thrives in cold, humid conditions with fertile forest soils and is harvested from wild or cultivated forests. Production involves cutting roots, soaking in ethanol for seven days, filtering, concentrating via rotary evaporation, and lyophilizing to achieve a 0.4% yield extract.
Historical & Cultural Context
CMG has been used in traditional Chinese medicine for over a century, harvested from Changbai Mountain forests and valued as a 'buried treasure medicine' or 'king of herbs' for vitality. It serves as the emblematic herb of Jilin Province and has been cultivated under Good Agricultural Practices (GAP) standards to meet pharmaceutical demands.
Health Benefits
• Enhanced exercise performance and endurance based on animal studies showing increased grip strength and swimming time (preliminary evidence) • Reduced fatigue markers including decreased serum lactate, ammonia, and creatine kinase levels (preliminary evidence from mouse models) • Improved muscle mass and strength demonstrated in dose-dependent animal studies (preliminary evidence) • Enhanced energy utilization and glucose economy post-exercise (preliminary evidence, p < 0.0001 in animal studies) • Traditional use for vitality support as a TCM herb for over a century (traditional evidence only)
How It Works
Ginsenosides from Changbai Mountain Ginseng — particularly Rg1 and Rb1 — activate the hypothalamic-pituitary-adrenal (HPA) axis and modulate glucocorticoid receptor sensitivity, blunting cortisol-driven fatigue responses under physical stress. Rg1 upregulates mitochondrial biogenesis via PGC-1α activation and enhances ATP synthesis efficiency, while Rb1 inhibits monoamine oxidase (MAO) activity and supports dopaminergic signaling to reduce perceived exertion. Additionally, these ginsenosides suppress pro-inflammatory cytokines (TNF-α, IL-6) and reduce oxidative stress by upregulating superoxide dismutase (SOD) and catalase enzyme activity in skeletal muscle tissue.
Scientific Research
Available research on CMG is limited to animal studies, with no human clinical trials or PMIDs identified. The primary evidence comes from a mouse study showing dose-dependent improvements in exercise performance, muscle mass, and fatigue markers with statistical significance (p < 0.0001). No human RCTs or meta-analyses specific to CMG were found in the research dossier.
Clinical Summary
Most available evidence for Changbai Mountain Ginseng's ergogenic effects derives from animal studies using mouse models, which demonstrated increased grip strength, extended swimming endurance, and significantly reduced serum lactate, ammonia, and creatine kinase levels following supplementation — suggesting reduced muscle damage and improved aerobic metabolism. Human clinical data specifically on Changbai Mountain Ginseng as a distinct regional variety is limited; broader Panax ginseng trials involving 30–200 participants have shown modest improvements in VO2 max and subjective fatigue using standardized extracts at 200–400 mg/day over 8–12 weeks. A key limitation is that few trials distinguish Changbai Mountain Ginseng from other Panax ginseng sources, making direct extrapolation difficult. Overall, the evidence is preliminary and promising but requires well-designed, placebo-controlled human trials to establish efficacy specific to this variety.
Nutritional Profile
Changbai Mountain Ginseng (Panax ginseng) is not a significant source of macronutrients in typical supplemental doses, but its dried root contains approximately 60-70% carbohydrates (including polysaccharides and ginsenan), 12-16% water, 10-14% fiber, and 8-12% protein by dry weight. Key bioactive compounds include: Ginsenosides (saponins) as primary actives at 2-8% total concentration in root, with major individual ginsenosides including Rb1 (0.5-1.5mg/g), Rb2, Rc, Rd (dammarane-type protopanaxadiols), Rg1, Re (0.3-1.2mg/g, protopanaxatriols), and Ro (oleanane-type). Changbai Mountain wild or semi-wild ginseng typically contains higher total ginsenoside concentrations (up to 8-12mg/g) compared to cultivated varieties. Polysaccharides (ginsenan PA, PB) are present at 10-20% dry weight with immunomodulatory properties. Polyacetylenes including panaxynol and panaxydol are present at trace levels (0.01-0.05%). Phytosterols including beta-sitosterol are present at approximately 0.1-0.3mg/g. Essential oils account for approximately 0.05-0.25% of dry weight. Peptides including malonyl ginsenosides contribute to bioactivity. Minerals include potassium (~6-8mg/g), calcium (~2-3mg/g), phosphorus (~2-4mg/g), magnesium (~0.5-1mg/g), and trace amounts of zinc, iron, and manganese. Vitamins are present in minor quantities including B vitamins (thiamine, riboflavin, B6) and ascorbic acid at low concentrations. Bioavailability note: Ginsenosides have poor direct oral bioavailability (estimated 2-5%); gut microbiota convert major ginsenosides (Rb1, Rc) into more bioavailable metabolites such as compound K (20-O-beta-D-glucopyranosyl-20(S)-protopanaxadiol), which is considered the primary systemically active form. Fat-soluble components benefit from co-ingestion with dietary fat.
Preparation & Dosage
No clinically studied human dosage ranges for CMG are available. Animal studies used ethanol extract preparations with 0.4% yield, but specific mg/kg doses were not quantified in available abstracts. Commercial forms include powder and honey-blended lozenges without established clinical dosing guidelines. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Rhodiola rosea, Cordyceps sinensis, Ashwagandha, Schisandra chinensis, American ginseng
Safety & Interactions
Changbai Mountain Ginseng is generally well tolerated at standard Panax ginseng doses (100–400 mg standardized extract daily), with the most commonly reported side effects including insomnia, headache, digestive upset, and mild blood pressure fluctuations, particularly at higher doses or with prolonged use exceeding 3 months. It carries a clinically significant interaction with warfarin, as ginsenosides may inhibit CYP2C9 enzyme activity and alter anticoagulant metabolism, increasing bleeding risk. It may also potentiate the hypoglycemic effects of insulin and oral antidiabetic drugs (e.g., metformin) by enhancing insulin sensitivity via GLUT4 translocation. Ginseng is contraindicated during pregnancy due to potential uterotonic effects of ginsenoside Rb1, and should be used cautiously in individuals with hormone-sensitive conditions, as some ginsenosides exhibit weak estrogen receptor agonist activity.